Trial document




drksid header

  DRKS00020380

Trial Description

start of 1:1-Block title

Title

Cross-sector care for children and adolescents with mentally ill and addicted parents – Children of mentally ill parents –network – CHIMPS-NET

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

CHIMPS-NET

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

In order to identify psychological stress in children and adolescents of mentally ill parents as early as possible, four special intervention programs (CHIMPS-therapy, CHIMPS-Prevention-single, CHIMPS-prevention-group, iCHIMPS) have been developed. These four intervention programs are based on the initial medical situation, indication and need of the families. Thereby, an individually tailored counseling service will be provided. With this current project, the four counseling approaches will be tested at 20 study sites in 15 federal states in Germany. Moreover, the interventions long-term efficacy will be evaluated.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

The central objectives of the study at hand are the implementation, evaluation and transfer of three evidence-based innovative forms of care (CIMPS-Therapy, CHIMPS-Prevention-Group, CHIMPS-Prevention-Single) for children and adolescents (aged 3 to 18 years) with mentally ill parents at the 21 participating study cites in 15 federal states of Germany. In addition, iCHIMPS, an online intervention based on the CHIMPS concept for the whole family, will be developed.
The four innovative forms of care include diagnostic, prevention and – if needed – therapy in order to treat psychological symptoms of children and adolescents as early as possible. Thereby, chronification will be prevented and the cycle of transgenerational transmissions of psychiatric disorders will be broken.
Each of the four interventions will be evaluated in a separate prospective, randomized-controlled trial (RCT); overall, four randomized-controlled trials will be performed. Each of the four control groups receives treatment as usual (TAU). Each of the four studies will include two groups: one intervention group (IG) and one control group (KG), i.e. CHIMPS-T vs. KG (TAU), CHIMPS-P-group vs. KG (TAU), CHIMPs-P-single vs. KG (TAU), iCHIMPS vs. KG (TAU).
Central psychosocial outcomes will be assessed at four time points (t1, t2, t3, t4) at baseline as well as after six, 12 and 18 months. Due to a longer development period, iCHIMPS will have three times of measurement over a period of nine months (baseline, post-intervention after 2 months as well as six-months-follow-up) within the project term. Outcomes will be assessed from the perspectives of the mentally ill parent, the partner (if available), every child and adolescent (0 – 9 years only external assessment; from 10 years of age additional self-assessment) and the professionals.
A special characteristic of the study at hand is the comprehensive accompanying evaluation of medical biometry, health economics and qualitative evaluation.
In addition, various sub-projects for systematic implementation will be conducted: optimization of pathway to care, Knowledge and skills of professionals, development of a screening instrument and external quality assurance. In order to evaluate the effect of these three implementation strategies, an implementation study with a cluster-randomized trial was designed. Nineteen clinical centers are taking part in the implementation study. Nine of the nineteen clinical centers will receive the support of one of the three implementation strategies, the other ten clinical centers make up the control group and do not get a specific implementation support. The allocation is randomized. With three questionnaires in our implementation study we want to identify factors hindering or promoting implementation processes.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

[---]*

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00020380
  •   2019/12/19
  •   [---]*
  •   yes
  •   Approved
  •   PV7072, Ethik-Kommission der Ärztekammer Hamburg
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  •   U1111-1244-6111 
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   F10-F19 -  Mental and behavioural disorders due to psychoactive substance use
  •   F20-F29 -  Schizophrenia, schizotypal and delusional disorders
  •   F30-F39 -  Mood [affective] disorders
  •   F40-F48 -  Neurotic, stress-related and somatoform disorders
  •   F50-F59 -  Behavioural syndromes associated with physiological disturbances and physical factors
  •   F60-F69 -  Disorders of adult personality and behaviour
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   CHIMPS-T (Children of mentally ill parents) is a family-oriented low-frequency brief therapy for diagnosis and treatment of mental disorders in children and adolescents. CHIMPS-T is based on a theory model, needs analyses and the pioneering studies of Williams Beardslee. The CHIMPS approach was tested, evaluated and manualized in an initial project (2007-2011).
    CHIMPS is constructed modularly. The complete program comprises (depending on the number of children) 8 sessions over a period of six months for a family with 2 children: preliminary talk, 2 sessions with the parents, 1 sessions with each child, 3 sessions with the whole family. The low-frequency approach (sessions every 2 to 3 weeks) allows families to integrate the intervention into their daily life. Upon request, the sessions will take place at the family’s home (home-treatment).
    Key topics of the intervention are the family coping with the parental disorder, family relations (couple’s relationship, parent-child-relationship, relationships with the family of origin, social network) as well as current and future support.
    The CHIMPS approach is not limited to any parental disorder and it addresses children and adolescents within a broad age range from birth to young adulthood. The intervention focusses on the mental health and quality of life of the children/adolescents in the context of the parental disorder. This family-oriented therapy will sufficiently treat most psychological symptoms in the children and adolescents; positive evaluation results confirm the efficacy of the CHIMPS approach. If necessary, children and adolescents with severe or chronic psychiatric disorders will be placed with registered therapists. The tasks of the CHIMPS-therapist also involve therapeutic case management as he/she interacts with other practitioners and with youth aid – during and after the intervention.
  •   CHIMPS-P-single is a family-oriented prevention for children and adolescents without signs of mental disorders in the initial screening. These families will receive the 3 family sessions from the modular CHIMPS intervention. The sessions will be carried out by a social worker (based on the Finnish model “Let’s talk about children (Solantaus), but in a family setting “Let’s talk WITH children”).
  •   The CHIMPS-P-group is a prevention with a multi-family setting based on the CHIMPS approach. The multi-family intervention comprises 8 sessions for children and adolescents without psychiatric disorders and their families: preliminary talk, one additional session with the family (if needed), multi-family group with three to six other families, concluding session.
  •   iCHIMPS is an online intervention. In terms of content, iCHIMPS is based on the CHIMPS program as well as on other evidence-based interventions of the study group. iCHIMPS will also be comprised of one module for children and adolescents as well as one module for parents; moreover; modules for the family system will be included. Overall, 8 consecutive online modules as well as elective modules will be included. These modules (e.g., dealing with difficult situations, emotion regulation, taboos and shame, self-worth) will be provided based on the specific constellation of children and adolescents of mentally ill parents. iCHIMPS will be completed by 2 booster session within a six months follow-up.
  •   All four investigated interventions (CHIMPS-T, CHIMPS-P-single, CHIMPS-P-group, iCHIMPS) will be compared with a corresponding control group. Thus, each of the four studies includes two groups: an intervention group (IG) and a control group (KG), i.e. CHIMPS-T vs. KG (TAU), CHIMPS-P-single vs. KG (TAU), CHIMPS-P-group vs. KG (TAU), iCHIMPS vs. KG (TAU). Families in these control groups will receive treatment as usual. The treatment as usual implies that families of the control group receive the treatment that is customary in regular care. Thus, these families normally don't receive any post-treatment. If, however, a member of a control group family appears to have an urgent need for treatment (every family receives a comprehensive diagnostic investigation at the beginning of the study), the respective family will be placed in the ambulatory care system.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Blinded
  •   assessor
  •   Control group receives no treatment
  •   Treatment
  •   Parallel
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Children’s and adolescent’s psychiatric symptomatology, assessed from the perspective of the parents by the Child Behaviour Checklist (CBCL 1,5-5; Achenbach & Rescorla, 2000), (CBCL 6-18R; Döpfner, Pflück, Kinnen, & Arbeitsgruppe Deutsche Child Behavior Checklist, 2014) 12 months after randomization.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Sociodemographic information of the parents, assessed from the perspective of the parents by ad-hoc items at the beginning of the study.
Psychiatric disorders of the children and adolescents, assessed from the perspective of the parents by the “Child Behaviour Checklist” (CBCL; Döpfner, Pflück, Kinnen & Arbeitsgruppe Deutsche Child Behavior Checklist, 2014) and from the perspective of the children/adolescents (from 10 years of age) by the “Youth Self Report” (YSR; Döpfner, Pflück, Kinnen & Arbeitsgruppe Deutsche Child Behavior Checklist, 2014) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Psychiatric disorders of the children and adolescents, assessed from the perspective of an external rater by the Kiddie-SADS (K-SADS-PL) (Delmo, Weiffenbach, Gabriel, Stadler & Poustka, 2001) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Psychiatric symptomatology of the children and adolescents, assessed from the perspective of an external rater by the “Global Assessment of Functioning” (GAF; Saß, Wittchen, Zaudig & Houben, 2003) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Mental health of the parents, assessed from the perspective of the parents by
the “Brief Symptom Inventory“ (BSI; Franke, 2000) at the beginning of the
study as well as six, 12 and 18 months after the randomization.
General anxiety of the parents, assessed from the perspective of the parents by the „Gerneralized Anxiety Disorder-7“ (GAD-7; Kroenke, Spitzer, Williams, Monahan, & Löwe, 2007) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Mental health of the parents, assessed from the perspective of the parents by the “Patient Health Questionnaire” (PHQ; PHQ; Löwe, Spitzer, Zipfel & Herzog, 2002) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Mental health of the parents, assessed from the perspective of an external rater by the “Global Assessment of Functioning” (GAF; Saß, Wittchen, Zaudig & Houben, 2003) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Health-related quality of life of the parents, assessed from the perspective of the parents by the “Short Form 12” (SF-12; Bullinger & Kirchberger, 1998) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Health-related quality of life of the parents, assessed from the perspective of the parents by the EQ-5D (Brooks, Rabin & Charro, 2003; Hinz, Klaiberg, Brahler & Konig, 2006) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Health-related quality of life of the children and adolescents, assessed from the perspective of the child/adolescent (from 10 years of age) and from the perspective of the parents by the Kidscreen-27 (The KIDSCREEN Group Europe, 2006) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Family functioning, assessed from the perspective of an external rater by the „Global Assessment of Relational Functioning“ (GARF; Saß, Wittchen, Zaudig & Houben, 2003) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Family functioning, assessed from the perspective of the parents and the children and adolescents (from 10 years of age) by the „Allgemeiner Familienfragebogen“ (FB-A; Cierpka & Frevert, 1995) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Social support of the parents, of the children and adolescents, assessed from the perspective of the parents, of the children and adolescents (from 10 years of age) by the „Oslo Social Support Questionnaire“ (OSSQ; Dalgard, 2006) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Parental stress coping, assessed from the perspective of the parents by the “Elterliches Belastungsinventar” (EBI; Tröster, 2010) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Treatment evaluation, assessed from the perspective of the parents, the children and adolescents (from 10 years of age) as well as from the therapist by the “Fragebogen zur Behandlungsbeurteilung” (FBB; Mattejat & Remschmidt, 1999) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Objectives of the treatment of the parents, the children and adolescents, assessed from the perspective of the parents and from the perspective of the children/adolescents (from 10 years of age) and from the perspective of the therapist by ad-hoc items at the beginning of the study.
Satisfaction with the treatment of the parents, of the children and adolescents, assessed from the perspective of the parents and from the perspective of the children/adolescents (from 10 years of age) by the “ZUF-8” (Schmidt, Lamprecht & Wittmann, 1989) six, 12 and 18 months after the randomization.
Therapeutic activity and therapeutic processes, assessed from the perspective of the therapist by the “Vergleichende Psychotherapy Prozess Skalen” (VPPS; Beutel et al., 2016) during the intervention.
Treatment costs of the children and adolescents, assessed from the perspective of an external rater by the German version of the "Children and adolescent mental health services receipt inventory" (CAMHSRI-DE; Kilian, Losert, McDaid, Park, Knapp, Beecham, Kusakovskaja, Murauskiene & the CAMHEE Project, 2009) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Treatment costs of the parents, assessed from the perspective of an external rater by the German version of the "Client Socioeconomic and Services Receipt Inventory" (CSSRI-DE; Roick, Kilian, Matschinger, Bernert, Mory & Angermeyer, 2001) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Family-oriented attitude, assessed from the clinical employee’s point of view by the German version of the “Family Focused Mental Health Practice Questionnaire” (Laser et al., 2019) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Implementation components, assessed from the clinical employee’s point of view by the German version of the “Implementation Components Questionnaire” (Laser, Skogøy, Maybery & Wiegand-Grefe, 2019) at the beginning of the study as well as six, 12 and 18 months after the randomization.
Implementation Satisfaction, assessed from the clinical employee’s point of view by the German version of the “Implementation Satisfaction Scale” (Laser, Skogøy, Maybery & Wiegand-Grefe, 2019) at the beginning of the study as well as six, 12 and 18 months after the randomization.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
  • Medical Center 
  • University Medical Center 
  • University Medical Center 
  • University Medical Center 
  • University Medical Center 
  • University Medical Center 
  • University Medical Center 
  • Medical Center 
  • University Medical Center 
  • Medical Center 
  • Medical Center 
  • University Medical Center 
  • University Medical Center 
  • University Medical Center 
  • Medical Center 
  • University Medical Center 
  • University Medical Center 
  • Medical Center 
  • University Medical Center 
  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Planned
  •   2020/04/01
  •   1200
  •   Multicenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   3   Years
  •   18   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

1. Familiy with at least one psychiatrically ill parent (all F-diagnoses in ICD-10) and at least one child between the age of 3 and 18 years.
2. Consent to participate in the study.
3. Sufficient knowledge of the German language of parents and children.
4. Insured with one of the participating insurance companies.
5. Consent to data processing of the insurance companies.
6. Consent to participation in special care (in case of interventions).

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Severe psychiatric disorders and impairments of parents or children with acute symptoms such as suicidal tendencies, severe depression, addictions, acute psychotic symptoms etc., which will not be sufficiently supplied by these new low-frequency interventions.

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Universitätsklinikum Hamburg-Eppendorf Klinik für Kinder- und Jugendpsychiatrie, -psychotherapie und -psychosomatik
    • Ms.  Prof. Dr.  Silke  Wiegand-Grefe 
    • Martinistrasse 52
    • 20246  Hamburg
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address other
    • Universitätsklinikum Hamburg-Eppendorf, Klinik unf Poliklinik für Psychiatrie und Psychotherapie
    • Ms.  Prof. Dr.  Anne  Karow 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    •   [---]*
    •   [---]*
    •   karow at uke.de
    •   [---]*
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Charité-Universitätsmedizin Berlin, Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters
    • Ms.  PD Dr.  Sibylle  Winter 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Charité – Universitätsmedizin Berlin, Klinik für Psychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Andreas  Heinz 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsmedizin Rostock, Klinik für Kinder- und Jugendpsychiatrie und -psychotherapie
    • Mr.  Prof. Dr.  Michael  Kölch 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Immanuel Klinik Rüdersdorf, Hochschulklinik für Psychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Martin  Heinze 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Evangelisches Klinikum Bethel, Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Michael  Siniatchkin 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Evangelisches Klinikum Bethel, Klinik für Psychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Martin  Drießen 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Köln, Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters
    • Mr.  Prof. Dr.  Stephan  Bender 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Köln, Klinik und Poliklinik für Psychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Frank  Jessen 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • LWL-Universitätsklinik Hamm der Ruhr-Universität Bochum, Klinik für Kinder- und Jugendpsychiatrie, Psychotherapie & Psychosomatik
    • Mr.  Prof. Dr.  Martin  Holtmann 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsmedizin Göttingen, Klinik für Psychosomatische Medizin und Psychotherapie
    • Mr.  Prof. Dr.  Eric  Leibing 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Tübingen, Psychiatrie, Psychosomatik und Psychotherapie im Kindes- und Jugendalter
    • Mr.  Prof. Dr.  Tobias  Renner 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Tübingen, Allgemeine Psychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Andreas  Fallgatter 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Freiburg, Klinik für Psychiatrie und Psychotherapie
    • Ms.  Prof. Dr. Dr.  Katharina  Domschke 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Josefinum Augsburg, Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie
    • Ms.  Prof. Dr.  Michele  Noterdaeme 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Bezirkskrankenhaus Augsburg, Klinik für Psychiatrie, Psychotherapie und Psychosomatik
    • Mr.  Prof. Dr.  Max  Schmauß 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Klinikum der Universität München, Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, -psychosomatik und psychotherapie
    • Mr.  Prof. Dr.  Gerd  Schulte-Körne 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Uniklinikum Saarland, Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Michael  Zemlin 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Magdeburg, Klinik für Kinder- und Jugendpsychiatrie
    • Mr.  Prof. Dr.  Hans  Flechtner 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Magdeburg, Klinik für Psychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Thomas  Frodl 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Leipzig, Klinik und Poliklinik für Psychiatrie und Psychotherapie
    • Ms.  PD Dr.  Christine  Rummel-Kluge 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Helios Kliniken Schwerin, Kinder- und Jugendpsychiatrie
    • Mr.  Dr.  Christian  Haase 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Helios Kliniken Schwerin, Psychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Andreas  Broocks 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Marburg, Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie
    • Ms.  Prof. Dr.  Katja  Becker 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Marburg, Psychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Tilo  Kircher 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Koblenz – Landau, Klinische Psychologie und Psychotherapie des Kindes- und Jugendalters
    • Ms.  Prof. Dr.  Tina  In-Albon 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Pfalzklinikum, Klinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie
    • Mr.  Dr.  Michael  Brünger 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Pfalzklinikum, Klinik für Psychiatrie, Psychosomatik und Psychotherapie
    • Ms.  Dr.  Sylvia  Claus 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Helios Klinikum Erfurt, Klinik für Kinder- und Jugendpsychiatrie, Psychotherapie und Psychosomatik
    • Mr.  Dr.  Ekkehart  Englert 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Helios Klinikum Erfurt, Psychiatrie, Psychotherapie und Psychosomatik
    • Mr.  Prof. Dr.  Ralf  Schlößer 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Bezirkskrankenhaus Günzburg, Universitätsklinikum Ulm, Klinik für Psychiatrie und Psychotherapie II der Universität Ulm
    • Mr.  Prof. Dr.  Thomas  Becker 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Frankfurt, Klinik für Psychiatrie, Psychosomatik und Psychotherapie
    • Mr.  Prof. Dr.  Andreas  Reif 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • DAK-Gesundheit
    • Ms.  Jennifer  Lenz 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Techniker Krankenkasse
    • Mr.  Rasmus  Weber 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Barmer
    • Ms.  Dr.  Ursula  Marschall 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • BKK Mobil Oil
    • Mr.  Thomas  Krull 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • KKH Kaufmännische Krankenkasse
    • Ms.  Julia  Roos 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • IKK Classic
    • Mr.  Steve  Hüttmann 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • AOK Hessen
    • Ms.  Heike  Plachetka 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universität Ulm, Institut für Psychologie und PädagogikAbteilung Klinische Psychologie und Psychotherapie
    • Mr.  Prof. Dr.  Harald  Baumeister 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Hamburg-Eppendorf, Institut und Poliklinik für Medizinische Psychologie
    • Ms.  Dr.  Silke  Pawils 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Heidelberg, Institut für Psychosoziale Prävention
    • Ms.  Prof. Dr.  Svenja  Taubner 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • AQUA-Institut
    • Mr.  Dr.  Gerald  Wilms 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Hamburg-Eppendorf, Zentrum für Experimentelle Medizin Institut für Medizinische Biometrie und Epidemiologie
    • Ms.  Prof. Dr.  Antonia  Zapf 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Hamburg-Eppendorf, Zentrum für Experimentelle MedizinInstitut für Medizinische Biometrie und Epidemiologie
    • Mr.  Prof. Dr.  Karl  Wegscheider 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Leibniz Universität Hannover, Center for Health Economics Research Hannover (CHERH)
    • Mr.  Prof. Dr.  Matthias  Graf von der Schulenburg 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Leibniz Universität Hannover, Center for Health Economics Research Hannover (CHERH)
    • Mr.  Dr.  Jan  Zeidler 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    •   [---]*
    •   [---]*
    •   jz at cherh.de
    •   [---]*
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Ulm, Klinik für Psychiatrie und Psychotherapie II der Universität Ulm, Bezirkskrankenhaus Günzburg Sektion Versorgungsforschung und Gesundheitsökonomie
    • Mr.  Prof. Dr.  Reinhold  Kilian 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Hamburg-Eppendorf, Institut und Poliklinik für Medizinische Psychologie
    • Mr.  PD Dr.  Jörg  Dirmaier 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • AFET Bundesverband für Erziehungshilfe e.V.
    • Ms.  Jutta  Decarli 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Dachverband Gemeindepsychiatrie
    • Ms.  Dr.  Birgit  Görres 
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • AOK Baden-Württemberg
    • Mareen  Reinhart 
    • Germany
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Universitätsklinikum Freiburg Klinik für Psychiatrie, Psychotherapie und Psychosomatik im Kindes- und Jugendalter
    • Mr.  Prof. Dr.  Christian  Fleischhaker 
    • Germany
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • LWL Klinik Gütersloh Klinik für Allgemeine Psychiatrie
    • Mr.  Prof. Dr.  Klaus  Kronmüller 
    • Germany
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Immanuel Klinik Rüdersdorf Kinder- und Jugendpsychiatrie, Psychotherapie und Psychosomatik
    • Mr.  Dr.  Roland  Burghardt 
    • Germany
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • Charité – Universitätsmedizin Berlin Klinik für Psychiatrie und Psychotherapie
    • Mr.  Prof. Dr.  Felix  Bermpohl 
    • Germany
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address scientific-contact
    • Universitätsklinikum Hamburg-EppendorfKlinik für Kinder- und Jugendpsychiatrie, -psychotherapie und -psychosomatik
    • Ms.  Prof. Dr.  Silke  Wiegand-Grefe 
    • Martinistrasse 52
    • 20246  Hamburg
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Universitätsklinikum Hamburg-EppendorfKlinik für Kinder- und Jugendpsychiatrie, -psychotherapie und -psychosomatik
    • Ms.  Prof. Dr.  Silke  Wiegand-Grefe 
    • Martinistrasse 52
    • 20246  Hamburg
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Innovationsausschuss beim GB-A
    • Postfach 120606
    • 10623  Berlin
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting planned
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.